Csenge Advisory Group’s PetMed Express PETS Stock Holding History

Csenge Advisory Group’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5	Closed	–	–	1118
2018 Q3	$0	Buy	+5	New	+$187	﹤0.01%	1457

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Csenge Advisory Group's PETS Position: Q4 2018 in Review

Csenge Advisory Group sold out of PetMed Express (PETS) in Q4 2018, closing a stake of 5 shares.

Csenge Advisory Group first reported a position in PETS in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 200 funds tracked by Wall St. Rank hold PETS as of Q4 2018.

Csenge Advisory Group reported no remaining PetMed Express position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 5 PetMed Express shares in Q4 2018.
Csenge Advisory Group first reported a position in PetMed Express in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's PetMed Express position peaked at $0 in Q3 2018.
200 funds tracked by Wall St. Rank held PetMed Express as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.